Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features

Area of Science:

• Immunology
• Genetics

Background:

• CD40, a TNF receptor family member, is crucial for B-cell proliferation, immunoglobulin isotype switching, and germinal center formation.
• CD40 activation typically occurs via its ligand CD154 on T cells.
• Mutations in CD40 or CD154 lead to hyper IgM syndrome (HIGM3 or HIGM1), characterized by specific antibody deficiencies and impaired germinal center formation.

Purpose of the Study:

• To provide a comprehensive overview of hyper IgM syndrome caused by CD40 mutations.
• To detail the clinical, genetic, and immunological features of patients with HIGM3.

Main Methods:

• Review of clinical data from patients with hyper IgM syndrome due to CD40 mutations.
• Analysis of genetic mutations associated with HIGM3.
• Immunological assessment of affected patients.

Main Results:

• CD40 mutations result in HIGM3, a combined immunodeficiency.
• Patients exhibit very low levels of IgG, IgA, and IgE, with normal or elevated IgM.
• Defective T-cell priming and impaired B-cell-dendritic cell interactions are observed.

Conclusions:

• CD40 mutations are a significant cause of hyper IgM syndrome.
• Understanding HIGM3 is critical for diagnosing and managing combined immunodeficiencies.
• The study highlights the essential role of CD40 in adaptive immunity.